-
California’s Billionaire Tax Battle
Wealthy residents of the state have put millions of dollars toward stopping a proposed 5 percent tax on their assets.
-
Justice Dept. Legal Threat Complicates Trump’s Pick for Fed Chair
An investigation of the Federal Reserve was thwarted on Friday, but a department appeal could reimpose an obstacle in Kevin Warsh’s path.
-
When Changing Your Address Leads to Losing Your Medicare Coverage
Using a post office box shouldn’t cost you your health insurance. But in one woman’s case, it sure seemed to.
-
JB Pritzker Wants to Be Judged on His Heart, Not His Money
The governor of Illinois and Trump antagonist has become a national figure for Democrats. Where will that lead?
-
Tim Kaine Is Forcing the Iran War Debate From the Minority
Senator Tim Kaine, Democrat of Virginia, has found a way to repeatedly occupy floor time and force all senators to take votes challenging President Trump’s use of military force.
-
Why Little Was Done to Head Off Oil’s Strait of Hormuz Problem
Geography and regional rivalries have prevented Gulf countries from finding a true alternative to the strait, which the war with Iran has effectively shut down.
-
Trump and Rubio’s Vision of War: The Art of Destroy and Deal
Unleashing his inner hawk, Secretary of State Marco Rubio plans President Trump’s military interventions. So far, they favor regime compliance, not change.
-
In Arizona, an Electric Utility Holds an Election, Open Only to Property Owners
Turning Point is involved, as is the Sierra Club. But voting rules that seem to echo feudalism exclude renters, favor large landowners and limit who can influence a Phoenix utility board.
-
Unraveling the Quantum Realm: How Physics Shapes Our Everyday Reality
Unraveling the Quantum Realm: How Physics Shapes Our Everyday Reality I still remember the first time I heard about quantum physics. I was sitting in a dusty university lecture hall, trying to keep my eyes open as the professor droned on about wave functions and particle duality. To be honest, it flew over my head,…
-
What’s New Pussycat? FDA Assists Drug Sponsors Requesting New Clinical Investigation Exclusivity
Key Takeaways – FDA explains what must be “new” to qualify for three years of non-patent market exclusivity. In a new draft Q&A guidance, FDA walks sponsors through what makes a clinical investigation “new,” how to support exclusivity requests, and how the agency will evaluate them — aiming to balance innovation incentives with timely generic…
